AngioScore Acquired By Spectranetics

Fremont-based AngioScore, a devleoper and manufacturer of balloon catheters used for cardiac surgery, has been acquired by Spectranetics, the two said Tuesday. Spectranetics will pay $230M plus unspecified earnout for AngioScore. AngioScore was venture backed by California Technology Ventures, Innomed Ventures, Linkagene LP, Pelion Ventures, Psilos Group Management, QuestMark Partners, Saints Capital and Telegraph Hill Partners.